To directly test whether the FXN promoter is rendered less active in FRDA, FXN transcriptional initiation was measured via metabolic labeling of nascent transcripts in two FRDA and two non-FRDA cell lines. The gene discussed is FXN; the disease is Friedreich ataxia.